InvestorsHub Logo
Followers 46
Posts 3151
Boards Moderated 0
Alias Born 05/22/2010

Re: None

Monday, 10/18/2021 1:19:11 AM

Monday, October 18, 2021 1:19:11 AM

Post# of 403061
BUY OUT? Not likely.
Best is CV19 license partnership , A lump sum plus x percentage goes to IP , the IP takes off down the road to develop Kevetrin.

But flexibility in thinking is needed here as there are a variety of attractive possibilities.

1. entire buyout of IPIX. ( the least logical and profitable approach)
2. A cash plus stock swap with a BP or some other larger entity. ( this is what I think is happening )
3. An arrangement between multiple companies. Where licensing deals cross geography. Say one US one non-US countries.
4. A deal that takes into account Kevetrin.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News